{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif
AsseSsment of Place and Use of NutraceutIcals in the Management of Musculoskeletal DisordeRs by Indian HEalthcare Professionals (ASPIRE Study)
Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Survey Questionnaire Form

  1. Years of Clinical Practice: *

  2. Type of Practice *

  3. How many patients of osteoarthritis (OA) do you see in a day in your practice? *

  4. How many patients of tendinopathy do you see in a day in your practice? *

  5. Which age group most commonly gets affected due to osteoarthritis in your practice? (Multiple options can be selected) *

  6. According to you, what is the role of nutritional supplements in the management of OA? (Multiple options can be selected) *

  7. Do you observe the advantages with nutritional supplements in the management of OA? If yes, per your clinical experience what are the advantages of nutritional supplements with anti-inflammatory properties compared to NSAIDs in the management of OA?
  8. Which supplements do you prefer in the management of osteoarthritis in your practice? (Multiple options can be selected) *

  9. What is the duration of therapy you recommend with nutritional supplement in OA? *

  10. Which type of collagen do you prefer in the management of Osteoarthritis and why? *
  11. In which grade of osteoarthritis do you prefer undenatured type II collagen? (Multiple options can be selected)*

  12. As per your clinical experience in the management of osteoarthritis, do you find undenatured type II collagen is more effective than other chondroprotective, anti-inflammatory, and antioxidant agents like glucosamine, chondroitin, ascorbic acid, Boswellia serrata, astaxanthin, etc.? *

  13. As per your clinical experience do you think use of NSAIDs can be avoided with the use of undenatured type II collagen in the management of osteoarthritis? *

  14. As per your clinical experience do you observe that undenatured type II collagen reduces joint stiffness and improves mobility in osteoarthritis? *

  15. Kindly share your experience with undenatured type II collagen for the management of osteoarthritis? *
  16. Have you used undenatured type II collagen in the management of RA & other inflammatory diseases of joints due to its anti-inflammatory effect? *

  17. In which disease conditions, do you prefer undenatured type 2 collagen and what are the observed advantages as per your clinical experience? *
  18. In your clinical practice how long do you prefer to prescribe oral NSAIDs in the management of OA? *

  19. In your clinical practice what is the average duration of undenatured type 2 collagen therapy in the management of OA? *

  20. Which combinations would you like to prefer along with undenatured type 2 collagen in OA management? *
  21. What scientific evidence would you prefer to have as to prescribe nutritional supplements in OA management? *
  22. In which cases, do you prescribe type 1 collagen? (List of indications) *
  23. What is your approach to treat tendinopathy in your clinical practice? *
  24. Do you think type 1 collagen preparations have role in the treatment of tendinopathy? *

  25. What combination do you prefer along with type 1 collagen in the management of bone and joint diseases? *
  26. According to you, what should be the ideal composition of supplement with type 1 collagen for the management of bone and joint diseases? *
  27. What according to you should be the ideal cost per tablet of type 1 collagen combination brand? *
  28. In your clinical practice, for how long do you prefer to prescribe type 1 collagen combination brand for the management of musculoskeletal disorders? *

  29. What % of your OA patients have tendinopathy as a concomitant ailment? *

  30. According to you what proportion of OA patients comply with nutritional supplement therapy? *

  31. According to you, what proportion of tendinopathy patients comply with nutritional supplement therapy? *

  32. As per your clinical experience is there a need of Type 1 and Type 2 collagen combination in OA management? *

  33. Are you aware of the Bone & Joint Patient Support Programme particularly for OA patients requiring UC-II combination therapy run by Sun Pharma? *

  34. If yes, how would you rate Bone & joint patient support programme on a scale of 1 – 5? (1 – poor & 5 – Very good)
  35. Apart from assistance on the overall cost of therapy containing UC-II, what else can be done to improve overall care of patients suffering from musculoskeletal disorders? *
  36. Do you think there is need to educate healthcare professionals about the unique properties of different types of collagens and their appropriate use in bone and joint disorders to get optimum therapeutic benefits? *